J. C. Martins, R. C. Bonadio, V. J. Yamamoto, and L. Testa, “Stage I human epidermal growth factor receptor-type 2-positive breast cancer: is systemic therapy required?”, MAST, vol. 35, no. suppl.1, Feb. 2026.